Archive - May 2018
FDA grants Keytruda priority review
MRC awards Bristol researcher £1.2M to investigate immune defence against microbes
FDA approval for Novartis’ melanoma combo
Kymriah (tisagenlecleucel) Receives Second FDA Approval to Treat Appropriate Patients with Large B-Cell Lymphoma